For the third year in a row, the hundreds of millions of dollars poured into commercials for AbbVie ... according to iSpot.TV, while Dupixent's total was about $100 million lower than Skyrizi ...
Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval ... in clinical trials improving atopic dermatitis (AD) in moderate-to-severe patients, where it is the first systemic ...